Data / Drug companies / Tobramycin
Tobramycin: 41 companies and 57 products in the FDA NDC directory
Tobramycin is listed in the FDA National Drug Code Directory by 41 companies, with 57 products in commercial distribution. 51 of the products (89.5%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are solution; solution/ drops; injection, and the newest product started marketing on July 15, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 41
- Products
- 57
- Generic (ANDA) products
- 51 (89.5%)
- Application numbers
- 28
- Routes
- Ophthalmic, Respiratory (inhalation), Intravenous, Intramuscular, Oral
- Brand names
- Kitabis Pak, Bethkis, Tobrex, Tobi, Tobi Podhaler
- openFDA record search
- api.fda.gov
Companies that list tobramycin
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Gland Pharma Limited | 5 | injection; injection, powder, lyophilized, for solution | Generic drugs (ANDA) | May 18, 2021 |
| NorthStar RxLLC | 3 | solution; injection, powder, lyophilized, for solution | Generic drugs (ANDA) | August 1, 2024 |
| Proficient Rx LP | 3 | solution; solution/ drops | Generic drugs (ANDA) | January 31, 1996 |
| A-S Medication Solutions | 2 | solution/ drops; solution | Generic drugs (ANDA) | August 11, 2020 |
| Asclemed USA, Inc. | 2 | solution; solution/ drops | Generic drugs (ANDA) | June 28, 2017 |
| Baxter Healthcare Corporation | 2 | injection | Generic drugs (ANDA) | July 15, 2016 |
| Lifestar Pharma LLC | 2 | solution | Generic drugs (ANDA) | June 30, 2023 |
| Mylan Institutional LLC | 2 | injection | Generic drugs (ANDA) | August 19, 2014 |
| Preferred Pharmaceuticals Inc. | 2 | solution; solution/ drops | Generic drugs (ANDA) | July 15, 2026 |
| Sportpharm LLC | 2 | solution; solution/ drops | Generic drugs (ANDA) | August 11, 2020 |
| Viatris Specialty LLC | 2 | solution; capsule | New drug applications (NDA) | June 23, 2022 |
| Advanced Rx of Tennessee, LLC | 1 | solution | Generic drugs (ANDA) | May 24, 2023 |
| American Health Packaging | 1 | solution | Generic drugs (ANDA) | May 19, 2024 |
| Amneal Pharmaceuticals LLC | 1 | solution | Generic drugs (ANDA) | July 13, 2014 |
| Ascend Laboratories, LLC | 1 | solution | Generic drugs (ANDA) | April 2, 2021 |
| Aurobindo Pharma Limited | 1 | solution | Generic drugs (ANDA) | January 22, 2021 |
| Bausch & Lomb Incorporated | 1 | solution | Generic drugs (ANDA) | November 29, 1993 |
| Belcher Pharmaceuticals, LLC | 1 | solution/ drops | Generic drugs (ANDA) | April 1, 2024 |
| Chiesi USA, Inc. | 1 | solution | New drug applications (NDA) | April 15, 2013 |
| Direct RX | 1 | solution/ drops | Generic drugs (ANDA) | April 23, 2019 |
| Eugia US LLC | 1 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | June 21, 2023 |
| Fosun Pharma USA Inc. | 1 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | August 11, 2021 |
| Genericus, Inc. | 1 | solution | Authorized generics (NDA) | July 11, 2016 |
| Hospira, Inc. | 1 | injection, solution | Generic drugs (ANDA) | May 5, 2005 |
| Jvet Pharmaceuticals LLC | 1 | solution/ drops | Generic drugs (ANDA) | January 26, 2026 |
| Lupin Pharmaceuticals, Inc. | 1 | solution | Generic drugs (ANDA) | June 12, 2018 |
| Novartis Pharmaceuticals Corporation | 1 | ointment | New drug applications (NDA) | June 28, 1981 |
| NuCare Pharmaceuticals, Inc. | 1 | solution | Generic drugs (ANDA) | November 29, 1993 |
| NuCare Pharmaceuticals,Inc. | 1 | solution/ drops | Generic drugs (ANDA) | June 28, 2017 |
| Pari Respiratory Equipment, Inc. | 1 | solution | New drug applications (NDA) | February 19, 2015 |
| Proficient Rx LP | 1 | solution/ drops | Generic drugs (ANDA) | July 5, 2017 |
| Remedyrepack Inc. | 1 | solution/ drops | Generic drugs (ANDA) | August 13, 2018 |
| Ritedose Pharmaceuticals, LLC | 1 | solution | Generic drugs (ANDA) | March 25, 2025 |
| Sandoz Inc | 1 | solution | Generic drugs (ANDA) | January 9, 1995 |
| Slate Run Pharmaceuticals, LLC | 1 | injection, powder, for solution | Generic drugs (ANDA) | February 1, 2023 |
| Somerset Therapeutics, LLC | 1 | solution/ drops | Generic drugs (ANDA) | August 11, 2020 |
| St. Mary's Medical Park Pharmacy | 1 | solution/ drops | Generic drugs (ANDA) | September 12, 2019 |
| Sun Pharmaceutical Industries, Inc. | 1 | solution | Generic drugs (ANDA) | February 28, 2020 |
| Teva Pharmaceuticals USA, Inc. | 1 | solution | Generic drugs (ANDA) | November 19, 2013 |
| XGen Pharmaceuticals DJB, Inc. | 1 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | August 17, 2001 |
| Xiromed, LLC | 1 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | July 12, 2021 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Solution | 26 | 45.6% |
| Solution/ drops | 14 | 24.6% |
| Injection | 7 | 12.3% |
| Injection, powder, lyophilized, for solution | 6 | 10.5% |
| Injection, powder, for solution | 1 | 1.8% |
| Injection, solution | 1 | 1.8% |
| Ointment | 1 | 1.8% |
| Capsule | 1 | 1.8% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 51 | 89.5% |
| New drug applications (NDA) | 5 | 8.8% |
| Authorized generics (NDA) | 1 | 1.8% |
Pharmacologic classes
| Class | Products |
|---|---|
| Aminoglycoside Antibacterial | 57 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.